Retractable Technologies Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Quarterly Earnings Release (Form 10-Q) | 13 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Quarterly Net Sales Quarterly7.2M
Quarterly Operating Loss Quarterly-6.2M
Domestic Sourcing Share (US Production) Quarterly39.0%
Watch Items
- Tariff Rates on Chinese ImportsTrigger: 120% on syringe and needle productsAction: Monitor domestic production ramp-up and shift of 0.5 mL syringe lines to Little Elm, Texas facility to mitigate tariff expenses.
- Workforce Reduction Savings RealizationTrigger: 16% workforce cut (approx. 36 positions)Action: Track the realization of the projected $2.2 million in annual wage and benefit savings (approx. 13% of total workforce costs) starting Q2 2026.
- EU MDR 2017/745 CertificationTrigger: Certification approval timelineAction: Monitor progress of VanishPoint and EasyPoint certifications to support international sales growth in H2 2026.
Research as of 20 Jun 2026